Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
 

This article is part of the supplement: Symposium Mammographicum 2004

Oral presentation

Determinants of false positive recall rates in an Australian mammographic screening programme

AM Kavanagh1, D Jolley2, A Chapman3, A Amos1, JN Cawson4, N Davidson3, L Heuzenroeder3, DM Gertig5 and J Evans6

1BreastScreen Victoria, Melbourne, Australia

2Deakin University, Melbourne, Australia

3Department of Human Services and Health, Melbourne, Australia

4St Vincents BreastScreen, Melbourne, Australia

5University of Melbourne, Australia

6Monash BreastScreen, Australia

from Symposium Mammographicum 2004
Edinburgh, UK. 19th – 20th July 2004

Breast Cancer Res 2004, 6(Suppl 1):P12doi:10.1186/bcr831

Published: 14 July 2004

Oral presentation

We assessed the clinical and service related determinants of false positive recall using a case–control study of women who attended BreastScreen Victoria between 1994 and 1999. Cases were randomly selected from all women who were recalled for assessment but did not have cancer (false positives), and controls were selected from women who had a negative assessment and did not have cancer. Separate analyses were conducted for first (n = 12,667) and subsequent rounds (n = 17,461).

To identify reader characteristics associated with false positive recall we conducted generalised linear modeling of all women who attended between 1994 and 1999.

In the case–control study year of screen, strong family history and age at screening were important predictors of false positive recall at first round. At subsequent rounds, age, time since introduction of Kodak MIN-R-2000 film, strong family history of breast cancer, hormone replacement therapy use, recall at previous screen, previous screen at more than 27 months and screening round were significant predictors.

In the analysis of reader characteristics, false positive recall rates were found to increase with increasing number of screening reads per reader over the preceding 12-month period, but the number of assessment clinics each reader had attended heavily modified this finding.

Have something to say? Post a comment on this article!


© 1999-2008 BioMed Central Ltd unless otherwise stated < info@breast-cancer-research.com >   Terms and conditions